Professor of Pharmacology, Addiction Science and Toxicology, University of Tennessee Health Science Center
Appears in 1 story
Co-investigator on OTULIN study
For three decades, Alzheimer's drug development has chased the wrong protein. Billions of dollars and hundreds of failed trials later, researchers at the University of New Mexico have identified OTULIN—an enzyme previously known only for regulating inflammation—as a master switch that controls whether tau protein is produced in the first place. When they disabled OTULIN in neurons, tau vanished entirely, and the cells remained healthy.
Updated Jan 18
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
